.png)
Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Two format notes
BPC-157, a stable gastric pentadecapeptide, works primarily through angiogenic (blood vessel formation) and nitric oxide pathways, showing particular efficacy in gastrointestinal, tendon, and ligament healing in animal models
Enough to sustain the GHK-Cu-driven remodeling signal without daily injections
Within this triple-peptide blend, Tesamorelin contributes a clinically validated GHRH receptor activation profile and a well-characterized metabolic downstream research footprint
The FDA removed both from compounding availability in 2024
Clinical studies in healthy volunteers have suggested that joint administration of a GHRH (e.g
US$ 28.70
US$ 27.54
US$ 21.44
US$ 23.62
US$ 21.14
